Category: Prescription Drugs
United States Prescription Drugs
-
U.S. Healthcare Discount Plan Market Size, Share & Trends Analysis Report By Service (Dental Care, Health Advocate, Virtual Visits, Alternative Medicines, Prescription Drugs, Vision Care), And Segment Forecasts, 2022 - 2030
... a new report by Grand View Research, Inc. Growing chronic diseases burden, increasing health expenses, and rising out-of-pocket expenditures are boosting the demand for health/medical discount plans offering affordable treatment solutions. Market players are focusing ... Read More
-
The U.S. Weight Loss Market: 2022 Status Report & Forecast
... for 2022 and the current “diet season”. The value of the total market is estimated to have declined by a historic 25% in 2020, to $58 billion. as a result of closures of weight loss ... Read More
-
United States Pain Management Therapeutics Market, Forecast 2022-2028, Industry Trends, Outlooks, Impact of COVID-19, Company Analysis
... has faced a crisis in the United States for years due to severe problems accessing sufficient care, resulting in considerable physical, emotional, and societal expenses. To treat pain caused by inflammation in reaction to tissue ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2028, NAIC 424200
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,687,403 million by 2028. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry ... Read More
-
Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027
... In 2020, the global Eosinophilic Asthma Treatment market size was US$ 9901 million and it is expected to reach US$ 98355 million by the end of 2027, with a CAGR of 38.99% during 2021-2027. In ... Read More
-
U.S. E-Prescribing Market - Industry Outlook & Forecast 2022-2027
... grow at a CAGR of 20.68% during the period 2022–2027. U.S. E-PRESCRIBING INDUSTRY INSIGHTS E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and ... Read More
-
Out-of-Pocket Healthcare Expenditures in the United States, 5th Edition
... States, 5th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures ... Read More
-
Pet Medications: United States
... the retail market for medications for domestic dogs and cats, centering on products purchased directly by consumers. These include prescription, over-the-counter (also called OTC or retail), and ""ethical"" products (nonprescription medications that are only distributed ... Read More
-
Pharmaceuticals: United States
... compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, respiratory, nutritional, digestive and genito-urinary, and dermatological. To illustrate historical trends, total demand, ... Read More
-
Pharmaceuticals Market USA Sep 2017
... market in the USA with deep market research. Provides expert insight into market drivers, challenges, and the competitive landscape facing the market with data from 2016. The purpose of this report is to provide deep ... Read More
-
Pet Medications in the U.S., 5th Edition
... and cats, with a particular focus on brand-name products used by consumers. These include prescription, over-the-counter (OTC or “retail”), and ethical products (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians). The primary ... Read More
-
Dermatological Drugs: United States
... drugs, skin cancer drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, hair loss and hair removal drugs, hyperpigmentation/melasma and depigmenting drugs, and other products. To illustrate historical trends, total demand and the various segments ... Read More
-
Sleep Management in the U.S.: Consumer Strategies
... that 82% of adults have trouble sleeping at least once a week, due to at least one of seven forms of sleep disturbance. This translates to 206 million “troubled sleepers” out of 249 million U.S. ... Read More
-
Pain Management in the U.S.: Consumer Strategies
... report studies two distinct groups: pain sufferers and adults who have selected illnesses/conditions strongly associated with physical pain and pain management. Demographic analysis of these groups is woven into report analysis. Content is further segmented ... Read More
Research Assistance
